Profy AT - Search Results

1

PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.

Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, Cole AL, Cole AM, Profy AT, Wira CR, Hogarty K, Herold BC. Keller MJ, et al. Among authors: profy at. AIDS. 2007 Feb 19;21(4):467-76. doi: 10.1097/QAD.0b013e328013d9b5. AIDS. 2007. PMID: 17301565 Clinical Trial.

2

PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.

Keller MJ, Zerhouni-Layachi B, Cheshenko N, John M, Hogarty K, Kasowitz A, Goldberg CL, Wallenstein S, Profy AT, Klotman ME, Herold BC. Keller MJ, et al. Among authors: profy at. J Infect Dis. 2006 Jan 1;193(1):27-35. doi: 10.1086/498533. Epub 2005 Nov 17. J Infect Dis. 2006. PMID: 16323128 Clinical Trial.

3

ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations.

Tuyama AC, Cheshenko N, Carlucci MJ, Li JH, Goldberg CL, Waller DP, Anderson RA, Profy AT, Klotman ME, Keller MJ, Herold BC. Tuyama AC, et al. Among authors: profy at. J Infect Dis. 2006 Sep 15;194(6):795-803. doi: 10.1086/506948. Epub 2006 Aug 16. J Infect Dis. 2006. PMID: 16941346

4

Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials.

Keller MJ, Mesquita PM, Torres NM, Cho S, Shust G, Madan RP, Cohen HW, Petrie J, Ford T, Soto-Torres L, Profy AT, Herold BC. Keller MJ, et al. Among authors: profy at. PLoS One. 2010 Jan 22;5(1):e8781. doi: 10.1371/journal.pone.0008781. PLoS One. 2010. PMID: 20107502 Free PMC article.

5

Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.

Cheshenko N, Keller MJ, MasCasullo V, Jarvis GA, Cheng H, John M, Li JH, Hogarty K, Anderson RA, Waller DP, Zaneveld LJ, Profy AT, Klotman ME, Herold BC. Cheshenko N, et al. Among authors: profy at. Antimicrob Agents Chemother. 2004 Jun;48(6):2025-36. doi: 10.1128/AAC.48.6.2025-2036.2004. Antimicrob Agents Chemother. 2004. PMID: 15155195 Free PMC article.

6

Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action.

Scordi-Bello IA, Mosoian A, He C, Chen Y, Cheng Y, Jarvis GA, Keller MJ, Hogarty K, Waller DP, Profy AT, Herold BC, Klotman ME. Scordi-Bello IA, et al. Among authors: profy at. Antimicrob Agents Chemother. 2005 Sep;49(9):3607-15. doi: 10.1128/AAC.49.9.3607-3615.2005. Antimicrob Agents Chemother. 2005. PMID: 16127029 Free PMC article.

7

Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety study.

Lacey CJ, Wright A, Weber JN, Profy AT. Lacey CJ, et al. Among authors: profy at. AIDS. 2006 Apr 24;20(7):1027-30. doi: 10.1097/01.aids.0000222075.83490.ca. AIDS. 2006. PMID: 16603855 Clinical Trial.

8

Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.

Mayer KH, Karim SA, Kelly C, Maslankowski L, Rees H, Profy AT, Day J, Welch J, Rosenberg Z; HIV Prevention Trials Network (HPTN) 020 Protocol Team. Mayer KH, et al. Among authors: profy at. AIDS. 2003 Feb 14;17(3):321-9. doi: 10.1097/00002030-200302140-00005. AIDS. 2003. PMID: 12556685 Clinical Trial.

9

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

Sachdev DD, Zerhouni-Layachi B, Ortigoza M, Profy AT, Tuen M, Hioe CE, Klotman ME. Sachdev DD, et al. Among authors: profy at. J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):125-9. doi: 10.1097/QAI.0b013e31819f9e31. J Acquir Immune Defic Syndr. 2009. PMID: 19349871 Free PMC article.

10

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.

Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L; HIV Prevention Trials Network (HPTN) 035 Study Team. Abdool Karim SS, et al. AIDS. 2011 Apr 24;25(7):957-66. doi: 10.1097/QAD.0b013e32834541d9. AIDS. 2011. PMID: 21330907 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page